Carmot Therapeutics

Developer of metabolic drugs designed to unlock novel therapeutic target space not currently accessible to conventional small-molecule technologies. The company’s drugs are made with proprietary chemotype evolution technology that helps in the rapid identification of novel drugs through an evolutionary lead-identification paradigm, enabling doctors to cure metabolic diseases, cancer, and inflammation.